✦ LIBER ✦

Pharmacokinetics of peptichemio in myeloma patients: release ofm-l-sarcolysin in vivo and in vitro

✍ Scribed by Hans Ehrsson; Rolf Lewensohn; Inger Wallin; Mats Hellström; Giampaolo Merlini; Bo Johansson

Publisher: Springer
Year: 1993
Tongue: English
Weight: 400 KB
Volume: 31
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00685669

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histamine release “in vivo” and “in vitr

Histamine release “in vivo” and “in vitro” induced by hypnotics in normal and atopic patients

✍ M. C. Laxenaire; J. L. Guéant; D. A. Moneret-Vautrin 📂 Article 📅 1992 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 311 KB

Comparison of the in vitro dissolution p

Comparison of the in vitro dissolution properties and in vivo steady-state pharmacokinetics of two sustained-release theophylline preparations

✍ Jonkman, J. H. G. ;Van Der Boon, W. J. V. ;Grasmeijer, G. 📂 Article 📅 1988 🏛 Springer 🌐 Dutch ⚖ 452 KB

In Vivo and In Vitro release of macromol

In Vivo and In Vitro release of macromolecules from polymeric drug delivery systems

✍ L. R. Brown; C. L. Wei; R. Langer 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 706 KB

Determination of in vivo and in vitro re

Determination of in vivo and in vitro release of theophylline aminoisobutanol in a prolonged-action system

✍ Leonard L. Kaplan 📂 Article 📅 1965 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB 👁 1 views

Apomine™, an inhibitor of HMG-CoA-reduct

Apomine™, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo

✍ Claire M. Edwards; Gabrielle Mueller; Anke J. Roelofs; Andrew Chantry; Mark Perr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 367 KB

## Abstract Apomine, a novel 1,1 bisphosphonate ester, increases the rate of degradation of HMG‐CoA reductase, inhibiting the mevalonate pathway and thereby blocking cholesterol biosynthesis. We have investigated whether Apomine can induce myeloma cell apoptosis __in vitro__ and modulate myeloma di

Development of a new controlled-release

Development of a new controlled-release formulation of chlorpheniramine maleate using in vitro/in vivo correlations

✍ Roger L. Williams; Robert A. Upton; Luann Ball; Richard L. Braun; Emil T. Lin; W 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB

Development of a controlled-released formulation of chlorpheniramine maleate is described, using in vitro/in vivo correlates, according to a process that has been termed "biorelevant dissolution". The process begins with simulations using several possible input rates combined with known disposition